← Toate temele

Sindrom Down

Dezvoltare și sprijin pentru sindromul Down.

57 de articole
Definiții și semne precoce · în curândGhiduri practice · în curândTeste orientative · în curândResurse pentru specialiști · în curând
StudiuSindrom DownÎncredere bună22.06.2026

Cytomegalovirus Pneumonia in Down Syndrome: A Case Report

A 50-year-old female with Down syndrome developed severe bilateral pneumonia caused by cytomegalovirus (CMV), requiring intensive care and mechanical ventilation, which resolved after ganciclovir treatment. This case highlights that CMV-induced pneumonia, rarely reported in Down syndrome patients, can be a life-threatening condition requiring early recognition and prompt antiviral intervention.

StudiuSindrom DownÎncredere bună22.06.2026

Interhemispheric Communication Efficiency in Down Syndrome: Evidence of Corpus Callosum Dysfunction

This study compared interhemispheric communication efficiency between 11 individuals with Down syndrome and 13 controls using a fingertip cross-localization test. Results showed significantly reduced interhemispheric transfer efficiency in the Down syndrome group, suggesting potential corpus callosum dysfunction that may contribute to cognitive development differences.

StudiuSindrom DownÎncredere înaltă22.06.2026

The etiology of atypical bone health in individuals with Down syndrome

This scoping review systematically analyzed existing research on bone growth, development, maintenance, and repair in individuals with Trisomy 21 (Down syndrome), identifying 16 relevant articles. Animal model studies revealed differences in bone development and reduced bone maintenance/repair, with evidence of osteoporotic bone phenotype in both male and female mice, highlighting the need for further understanding of bone health complications in this population.

StudiuSindrom DownÎncredere bună21.06.2026

Hyperkeratosis in Skin Dimples in Children With Down Syndrome

This clinical study documents a congenital dermatological finding in 39 children with Down syndrome characterized by rough, brownish skin in knee and elbow dimples, confirmed by dermoscopy and biopsy showing hyperkeratosis and papillomatosis. The condition was observed to resolve spontaneously in followed cases and may represent a characteristic skin marker associated with Down syndrome.

StudiuSindrom DownÎncredere bună21.06.2026

Precision Medicine for Treating Alzheimer's Disease in Down Syndrome

Individuals with Down syndrome have significantly elevated risk for early-onset Alzheimer's disease due to trisomy 21-related pathophysiology. Precision medicine approaches aim to tailor interventions based on individual genetic and biochemical profiles to improve outcomes in this high-risk population.

StudiuSindrom DownÎncredere bună21.06.2026

Infertility in Down Syndrome

This article addresses reproductive health and fertility outcomes in individuals with Down syndrome. The topic examines the biological and medical factors affecting reproductive capacity in this population.

StudiuSindrom DownÎncredere înaltă21.06.2026

Domain-Specific Age at Onset of Decline in Down Syndrome

This research investigates the timing and pattern of cognitive and functional decline across different developmental domains in individuals with Down syndrome. The study identifies age-related deterioration in specific areas, providing important insights for clinical monitoring and intervention planning throughout the lifespan.

StudiuSindrom DownÎncredere înaltă21.06.2026

Autoimmune Thyroid Disease in Patients with Down Syndrome—A Clinical Review

Down syndrome patients show significantly elevated prevalence of autoimmune thyroid diseases (Hashimoto's thyroiditis and Graves' disease) compared to age-matched controls without the chromosomal abnormality. These conditions manifest at earlier ages in Down syndrome populations and do not correlate with gender or family history of autoimmune disease.

StudiuSindrom DownÎncredere bună21.06.2026

Mitochondrial Dysfunction in Down Syndrome-Associated Alzheimer's Disease

This research examines the role of mitochondrial dysfunction as a biological mechanism contributing to Alzheimer's disease development in individuals with Down syndrome. The study explores cellular energy production impairment and related pathological processes underlying early-onset dementia in this population.

StudiuSindrom DownÎncredere înaltă21.06.2026

Down Syndrome is Not a Curse: Parent Perspectives on the Medicalization of Down Syndrome

A survey of 532 parents/caregivers of people with Down syndrome explored attitudes toward potential therapeutic interventions to improve neurocognition and phenotype. Responses revealed tensions between desires to enhance quality of life and concerns about erasing identity and personality, with some rejecting interventions as ableist and promoting the erasure of neurodiversity.

StudiuSindrom DownÎncredere înaltă21.06.2026

Amyloidogenic biomarkers in Down syndrome

This specialist research examines biomarkers associated with amyloid protein pathology in individuals with Down syndrome, who have elevated risk for early-onset Alzheimer's disease. Understanding these molecular markers may help identify progression and guide early interventions in this population.

StudiuSindrom DownÎncredere înaltă20.06.2026

Aberrant tissue mechanics and mechanotransduction during heart development in Down syndrome

This study investigates how altered extracellular matrix composition and increased tissue stiffness in Down syndrome contribute to congenital heart defects, particularly septal defects which occur in 70% of individuals with the condition. Using mouse models and iPSC-derived cardiomyocytes with trisomy 21, researchers found that increased collagen and hyaluronic acid stiffness impairs cardiomyocyte proliferation and sarcomere organization, disrupting normal heart development through mechanotransduction pathways.

StudiuSindrom DownÎncredere înaltă20.06.2026

Detection of Down Syndrome-Associated Arthritis: Development and Feasibility of a Musculoskeletal Screening Tool

This multicenter study developed and piloted a Down syndrome-specific musculoskeletal screening tool to identify inflammatory arthritis (DA) in individuals with DS, finding a 2% confirmed diagnosis rate among positive screens. The tool is simple and feasible for clinical use, with symptoms of joint swelling, redness, warmth, and stiffness being most predictive of DA.